The Epidemiology of Bile Acid Diarrhea in Denmark [Response to Letter].
作者信息
Kårhus Martin L, Ellegaard Anne-Marie, Knop Filip K, Kårhus Line L
机构信息
Center for Clinical Metabolic Research, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.
Steno Diabetes Center Copenhagen, Herlev, Denmark.
出版信息
Clin Epidemiol. 2024 Jan 16;16:7-8. doi: 10.2147/CLEP.S455102. eCollection 2024.
Abstract
摘要
相似文献
1
The Epidemiology of Bile Acid Diarrhea in Denmark [Response to Letter].丹麦胆汁酸腹泻的流行病学[对信件的回复]
Clin Epidemiol. 2024 Jan 16;16:7-8. doi: 10.2147/CLEP.S455102. eCollection 2024.
2
Author Response to Letter to the Editor regarding "the Epidemiology of Bile Acid Diarrhea in Denmark" [Response to Letter].作者对关于《丹麦胆汁酸腹泻的流行病学》的致编辑信的回复[回复信]
Clin Epidemiol. 2024 Jan 16;16:5-6. doi: 10.2147/CLEP.S455103. eCollection 2024.
3
The Epidemiology of Bile Acid Diarrhea in Denmark [Letter].丹麦胆汁酸腹泻的流行病学[信件]
Clin Epidemiol. 2023 Dec 15;15:1223-1224. doi: 10.2147/CLEP.S453992. eCollection 2023.
4
The Epidemiology of Bile Acid Diarrhea in Denmark [Letter].丹麦胆汁酸腹泻的流行病学[信函]
Clin Epidemiol. 2023 Dec 15;15:1225-1226. doi: 10.2147/CLEP.S454145. eCollection 2023.
5
Letter: post-infective bile acid malabsorption and diarrhoea.信件：感染后胆汁酸吸收不良与腹泻
Aliment Pharmacol Ther. 2019 Jul;50(1):109. doi: 10.1111/apt.15260.
6
Letter: post-infective bile acid malabsorption and diarrhoea. Authors' reply.信函：感染后胆汁酸吸收不良与腹泻。作者回复。
Aliment Pharmacol Ther. 2019 Jul;50(1):110-111. doi: 10.1111/apt.15301.
7
Letter: hydroxypropyl cellulose as therapy for chronic diarrhoea in patients with bile acid malabsorption - possible mechanisms.信函：羟丙基纤维素作为胆汁酸吸收不良患者慢性腹泻的治疗方法——可能的机制
Aliment Pharmacol Ther. 2016 Aug;44(3):306-7. doi: 10.1111/apt.13678.
8
Prevalence and clinical features of bile acid diarrhea in patients with chronic diarrhea.慢性腹泻患者胆汁酸腹泻的患病率和临床特征。
J Dig Dis. 2021 Feb;22(2):108-112. doi: 10.1111/1751-2980.12969. Epub 2021 Feb 3.
9
A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.一种新的胆酸腹泻机制：胆酸生物合成的反馈抑制缺陷。
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1189-94. doi: 10.1016/j.cgh.2009.04.024. Epub 2009 May 6.
10
Bile acid diarrhea.胆汁酸腹泻
Dig Dis. 1998 Mar-Apr;16(2):118-24. doi: 10.1159/000016855.
本文引用的文献
1
The Epidemiology of Bile Acid Diarrhea in Denmark.丹麦胆汁酸腹泻的流行病学
Clin Epidemiol. 2023 Dec 7;15:1173-1181. doi: 10.2147/CLEP.S442054. eCollection 2023.
2
Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea.每周一次和每日一次给药的GLP-1受体激动剂司美格鲁肽和利拉鲁肽对胆汁酸腹泻的不同影响。
JCEM Case Rep. 2022 Nov 29;1(1):luac004. doi: 10.1210/jcemcr/luac004. eCollection 2023 Jan.
3
Emerging uses of glucagon-like peptide 1 (GLP-1) receptor agonists following ileal resection: literature review and case examples.胰高血糖素样肽-1（GLP-1）受体激动剂在回肠切除术后的新用途：文献综述与病例示例
Frontline Gastroenterol. 2023 Jul 6;14(6):521-526. doi: 10.1136/flgastro-2023-102402. eCollection 2023.
4
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea.为了筛选真实世界数据中的附加药物获益，提出以下案例：胰高血糖素样肽 1 受体激动剂和胆汁酸腹泻。
Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5673. doi: 10.1002/pds.5673. Epub 2023 Aug 9.
5
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial.利拉鲁肽与考来维仑治疗胆汁酸腹泻的安全性和有效性：一项随机、双盲、阳性对照、非劣效性临床试验。
Lancet Gastroenterol Hepatol. 2022 Oct;7(10):922-931. doi: 10.1016/S2468-1253(22)00198-4. Epub 2022 Jul 20.
6
Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide.使用胰高血糖素样肽-1受体激动剂利拉鲁肽治疗后胆汁酸吸收不良症状的缓解
Gastroenterology. 2019 Aug;157(2):569-571. doi: 10.1053/j.gastro.2019.04.002. Epub 2019 Apr 6.
7
Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use--A Descriptive Cross-Sectional Study.丹麦五个地区在人口特征、医疗保健利用和药物使用方面的比较——一项描述性横断面研究。
PLoS One. 2015 Oct 6;10(10):e0140197. doi: 10.1371/journal.pone.0140197. eCollection 2015.
8
Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.腹泻型肠易激综合征患者中肠易激综合征生活质量（IBS-QOL）问卷的评估。
Health Qual Life Outcomes. 2013 Dec 13;11:208. doi: 10.1186/1477-7525-11-208.
9
Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.肠易激综合征患者的健康相关生活质量、工作效率及医疗资源利用情况：来自加拿大胃肠道症状纵向结局研究（LOGIC）的基线结果，一项自然主义研究。
Clin Ther. 2006 Oct;28(10):1726-35; discussion 1710-1. doi: 10.1016/j.clinthera.2006.10.010.
Zotero 插件